History · April 2026
A history of kava.
Direct answer
Kava (Piper methysticum) was first cultivated in northern Vanuatu roughly 3,000 years ago, spread across the Pacific with Austronesian voyagers, entered European markets in the 20th century, hit a major regulatory setback with the 2002 FDA advisory, recovered after WHO investigation vindicated traditional noble preparation, and is now experiencing a US commercial renaissance.
Timeline
Kava cultivation likely begins in northern Vanuatu. Piper methysticum is a sterile cultigen — it does not reproduce from seed, only via cuttings, which tells us humans have been propagating it for millennia.
Austronesian voyagers carry kava eastward during the great Pacific migrations — to Fiji, Samoa, Tonga, and eventually Hawaii.
Captain James Cook's crew documents the kava ceremony during the first European encounter with the practice in Tonga.
Kavain is first isolated by German pharmacologist Lewin — the first kavalactone identified.
Kava enters European herbal medicine markets as an anxiolytic and diuretic. Sold in pharmacies throughout the 20th century.
Kava surges in the European supplement market. Extract-based products dominate, often poorly characterized in terms of cultivar.
FDA issues consumer advisory on kava-associated liver injury reports from Europe.
Germany, Canada, and several European countries ban kava. Vanuatu economy (heavily kava-export dependent) takes significant hit.
WHO and independent reviews identify solvent extraction and tudei cultivars as likely hepatotoxicity drivers. Noble aqueous preparation vindicated.
Vanuatu Kava Act formalizes noble-cultivar export requirements to protect market.
Germany lifts kava ban. UK and most other countries follow within several years.
US kava bar boom. Florida alone reaches 150+ dedicated kava bars. Canned kava brands (Mitra 9, Leilo, TRU Kava) enter mainstream retail.
Kava Society and other advocacy groups push for cultivar labeling standards in US retail.
Why kava is a sterile cultigen
Piper methysticum does not produce viable seeds. Every kava plant in the world today descends from cuttings taken from other kava plants — a chain of human-mediated propagation stretching back thousands of years. This is one of the clearest markers that Pacific islanders were deliberately selecting and cultivating kava for at least 2–3 millennia before European contact.
It also explains why cultivars matter. Each cultivar (Borogu, Melomelo, Mahakea, etc.) is a genetic lineage maintained by Pacific farmers through selective cutting. Tudei strains are similarly maintained — though once upon a time deliberately, for specific ceremonial use, and now inadvertently in low-quality commercial supply.
The 2002 advisory and what really happened
The 2002 FDA consumer advisory was based on ~30 European case reports of liver injury associated with kava supplement use. Germany reacted first and hardest with a full ban. Other European countries followed. The Vanuatu economy — heavily dependent on kava export — crashed.
Subsequent analyses found that:
- Most cases involved solvent-extracted kava products (acetone, ethanol), not traditional water preparation.
- Several cases involved tudei cultivars marketed as premium kava.
- Many cases involved concurrent alcohol or Tylenol use.
- Several cases involved pre-existing liver conditions.
The WHO concluded in 2007 that traditional aqueous preparation of noble kava had an excellent safety record. Most European bans have since been lifted.
The US kava bar boom
Starting in the mid-2010s, US kava bars proliferated — first in Florida, then Texas, Colorado, and the Pacific Northwest. The sober-curious movement and disinterest in alcohol among younger consumers have driven demand. As of 2026, there are 300+ dedicated kava bars across the US and canned kava beverages are stocked at every smoke shop chain.
The challenge now is cultivar labeling — not all canned kava is noble, and not all US imports clearly identify their source.